Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 45-50 , January 2006

Radiation Combined With Antiangiogenic and Antivascular Agents

  • Michael S. O’Reilly, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Michael S. O’Reilly, MD, Departments of Radiation Oncology and Cancer Biology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.

References 

  1. O’Reilly MS . Antiangiogenesis (basic principles) . In:  Rosenberg SA editors. Principles and Practice of the Biologic Therapy of Cancer . Third edition. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 827–843
  2. Jain RK . Normalizing tumor vasculature with anti-angiogenic therapy (A new paradigm for combination therapy) . Nat Med . 2001;7:987–989
  3. Konerding MA , Malkusch W , Klapthor B , et al.   Evidence for characteristic vascular patterns in solid tumours (Quantitative studies using corrosion casts) . Br J Cancer . 1999;80:724–732
  4. Dvorak HF . Tumors (Wounds that do not heal) . N Engl J Med . 1986;315:1650–1659
  5. Rak J , Filmus J , Kerbel RS . Reciprocal paracrine interactions between tumour cells and endothelial cells (The ‘angiogenesis progression’ hypothesis) . Eur J Cancer . 1996;32A:2438–2450
  6. Folkman J . Tumor angiogenesis and tissue factor . Nat Med . 1996;2:167–168
  7. Hurwitz H . Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer . Clin Colorectal Cancer . 2004;4(suppl 2):S62–S68
  8. Huang X , Molema G , King S , et al.   Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature . Science . 1997;275:547–550
  9. Thorpe PE . Vascular targeting agents as cancer therapeutics . Clin Cancer Res . 2004;10:415–427
  10. Arap W , Pasqualini R , Ruoslahti E . Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model . Science . 1998;279:377–380
  11. Horsman MR , Murata R . Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response . Int J Radiat Oncol Biol Phys . 2003;57:1047–1055
  12. Siemann DW , Rojiani AM . Enhancement of radiation therapy by the novel vascular targeting agent ZD6126 . Int J Radiat Oncol Biol Phys . 2002;53:164–171
  13. Raben D , Bianco C , Damiano V , et al.   Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model . Mol Cancer Ther . 2004;3:977–983
  14. Wachsberger PR , Burd R , Marero N , et al.   Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma . Clin Cancer Res . 2005;11:835–842
  15. Garcia-Barros M , Paris F , Cordon-Cardo C , et al.   Tumor response to radiotherapy regulated by endothelial cell apoptosis . Science . 2003;300:1155–1159
  16. O’Reilly MS , Holmgren L , Chen C , et al.   Angiostatin induces and sustains dormancy of human primary tumors in mice . Nat Med . 1996;2:689–692
  17. Ezekowitz RAB , Mulliken JB , Folkman J . Interferon alfa-2a therapy for life-threatening hemangiomas of infancy . N. Engl J Med . 1992;326:1456–1463
  18. Kaban LB , Mulliken JB , Ezekowitz RA , et al.   Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a . Pediatrics . 1999;103:1145–1149
  19. Boehm T , Folkman J , Browder T , et al.   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance . Nature . 1997;390:404–407
  20. Hobson B , Denekamp J . Endothelial proliferation in tumors and normal tissues (Continuous labeling studies) . Br J Cancer . 1984;49:405–413
  21. Gorski DH , Beckett MA , Jaskowiak NT , et al.   Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation . Cancer Res . 1999;59:3374–3378
  22. Kaplan H , Murphy E . The effect of local roentgen irradiation on the biological behavior of a transplantable mouse carcinoma. Increased frequency of pulmonary metastasis . J Natl Cancer Inst . 1949;9:407–413
  23. Suit H , Sedlacek R , Gillette E . Examination for a correlation between probabilities of development of distant metastasis and local recurrence . Radiology . 1970;95:189–194
  24. Hast J , Schiffer IB , Neugebauer B , et al.   Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice . Anticancer Res . 2002;22:677–688
  25. Camphausen K , Moses MA , Beecken WD , et al.   Radiation therapy to a primary tumor accelerates metastatic growth in mice . Cancer Res . 2001;61:2207–2211
  26. Milas L . Tumor bed effect in murine tumors (Relationship to tumor take and tumor macrophage content) . Radiat Res . 1990;123:232–236
  27. Hartford AC , Gohongi T , Fukumura D , et al.   Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site (Potential role of host-tumor interaction) . Cancer Res . 2000;60:2128–2131
  28. Teicher BA , Dupuis N , Kusomoto T , et al.   Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy . Radiat Oncol Invest . 1995;2:269–276
  29. Murata R , Nishimura Y , Hiraoka M . An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma . Int J Radiat Oncol Biol Phys . 1997;37:1107–1113
  30. Lund EL , Bastholm L , Kristjansen PE . Therapeutic synergy of TNP-470 and ionizing radiation (Effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts) . Clin Cancer Res . 2000;6:971–978
  31. Mauceri HJ , Hanna NN , Beckett MA , et al.   Combined effects of angiostatin and ionizing radiation in antitumour therapy . Nature . 1998;394:287–291
  32. Milas L , Mason K , Hunter N , et al.   In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody . Clin Cancer Res . 2000;6:701–708
  33. Liao Z , Komaki R , Milas L , et al.   A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer . Clin Cancer Res . 2005;11:3342–3348
  34. Baker CH , McCarty MF , Tsan R , et al.   Phenotypic diversity of organ-specific endothelial cells . Proc Am Assoc Cancer Res . 2001;42:2186; (abstr)
  35. Raben D , Helfrich B , Chan DC , et al.   The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer . Clin Cancer Res . 2005;11:795–805
  36. Huang SM , Harari PM . Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas (Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis) . Clin Cancer Res . 2000;6:2166–2174
  37. Huang SM , Li J , Armstrong EA , et al.   Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa) . Cancer Res . 2002;62:4300–4306
  38. Chinnaiyan P , Huang S , Vallabhaneni G , et al.   Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva) . Cancer Res . 2005;65:3328–3335
  39. Brogi E , Wu T , Namiki A , et al.   Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only . Circulation . 1994;90:649–652
  40. Uehara H , Kim SJ , Karashima T , et al.   Blockade of the PDGF-R signaling by STI571 inhibits angiogenesis and growth of human prostate cancer cells in the bone of nude mice . Proc Am Assoc Cancer Res . 2001;42:2192; (abstr)
  41. Schueneman AJ , Himmelfarb E , Geng L , et al.   SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models . Cancer Res . 2003;63:4009–4016
  42. Hansen-Algenstaedt N , Stoll BR , Padera TP , et al.   Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy . Cancer Res . 2000;60:4556–4560
  43. Lee CG , Heijn M , di Tomaso E , et al.   Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions . Cancer Res . 2000;60:5565–5570
  44. Hess C , Vuong V , Hegyi I , et al.   Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth . Br J Cancer . 2001;85:2010–2016
  45. Geng L , Donnelly E , McMahon G , et al.   Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy . Cancer Res . 2001;61:2413–2419
  46. Kozin S , Boucher Y , Hicklin DJ , et al.   Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts . Cancer Res . 2001;61:39–44
  47. Schuuring J , Bussink J , Bernsen HJJ , et al.   Irradiation combined with SU5416 (Microvascular changes and growth delay in a human xenograft glioblastoma tumor line) . Int J Radiat Oncol Biol Phys . 2005;61:529–534
  48. Gorski DH , Mauceri HJ , Salloum RM , et al.   Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin . Cancer Res . 1998;58:5686–5689
  49. Ning S , Laird D , Cherrington JM , et al.   The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation . Radiat Res . 2002;157:45–51
  50. Williams KJ , Telfer BA , Brave S , et al.   ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy (Schedule-dependent enhancement of antitumor activity) . Clin Cancer Res . 2004;10:8587–8593
  51. Zips D , Hessel F , Krause M , et al.   Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice . Int J Radiat Oncol Biol Phys . 2005;61:908–914
  52. Winkler F , Kozin SV , Tong RT , et al.   Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation (Role of oxygenation, angiopoietin-1, and matrix metalloproteinases) . Cancer Cell . 2004;6:553–563
  53. Teicher BA , Sotomayor EA , Huang ZD . Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease . Cancer Res . 1992;52:6702–6704
  54. Bischof M , Abdollahi A , Gong P , et al.   Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells . Int J Radiat Oncol Biol Phys . 2004;60:1220–1232
  55. Huber PE , Bischof M , Jenne J , et al.   Trimodal cancer treatment (Beneficial effects of combined antiangiogenesis, radiation, and chemotherapy) . Cancer Res . 2005;65:3643–3655

PII: S1053-4296(05)00050-0

doi: 10.1016/j.semradonc.2005.08.006

Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 45-50 , January 2006

Article Tools

* Image Usage & Resolution